학술논문

Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naive HIV-Infected Patients: Results of the ENCORE1 Study
Document Type
Journal
Source
CLINICAL PHARMACOLOGY & THERAPEUTICS; OCT 2015, 98 4, p406-p416, 11p.
Subject
Language
English
ISSN
15326535